In nasopharyngeal carcinoma, AMP-activated protein kinase (AMPK), and cyclin-dependent kinase 1 (CDK1) axis activity determines the balance of DRP1 phosphorylation at Ser616 and Ser637, leading to chemoresistance [34]. This evidence concerns the gene DNM1L and nasopharyngeal carcinoma.